Syndax Pharmaceuticals Inc (SNDX) — Cash Flow Quality Index
Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Quality Index of 1.05x as of December 2021. Operating cash flow of $100.71 Million exceeds net income of $96.20 Million, indicating high earnings quality where cash backs reported profits. Explore Syndax Pharmaceuticals Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Syndax Pharmaceuticals Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Syndax Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Syndax Pharmaceuticals Inc (SNDX) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year earnings quality comparison for Syndax Pharmaceuticals Inc. For live market cap and the full company financial profile, see SNDX market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.17x | $29.13 Million | $24.93 Million | — |